Latest round: IPO. Jonathan Freve was the CFO at Galecto, a NASDAQ-listed clinical-stage biotechnology company with locations in Copenhagen and Boston.
Jonathan Freve was the CFO at Galecto, a NASDAQ-listed clinical-stage biotechnology company with locations in Copenhagen and Boston, where he led the IPO process in 2020. He has more than 25 years of financial experience in biotech. Prior to Galecto, he served as CFO and Treasurer of Spring Bank Pharmaceuticals, and was also at Santaris Pharma.
Full founder directory · Investor directory · Company funding database · Fundraising library